New mesh aims to improve breast reconstruction safety and appearance

NCT ID NCT07480421

Not yet recruiting Disease control Sponsor: Silimed Industria de Implantes Ltda Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new acellular matrix (a supportive mesh) used with breast implants for immediate reconstruction after mastectomy. The goal is to see if it is safe and helps maintain breast shape and function. One hundred women born female who need breast reconstruction will be enrolled and followed for complications and cosmetic results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: acellular matrix (a supportive mesh made from processed tissue)
What this could lead to: If it works, this could provide a safer, more effective way to support breast reconstruction after mastectomy, reducing complications and improving cosmetic outcomes.
What could go wrong: This is an early-stage study with only 100 participants, so results may not apply to everyone. Risks include infection, poor integration, or implant failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST RECONSTRUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST RECONSTRUCTION

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Hospital de câncer HCIII (INCA)

Rio de Janeiro, Rio de Janeiro, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.